Compass Point analyst Michael Donovan initiated coverage of SharonAI with a Buy rating and $50 price target. With primary operations in Australia, the company focuses on AI and high-performance computing infrastructure, the analyst tells investors in a research note. The firm believes SharonAI's first major contract moves it beyond setup and into contract-backed scale. In addition, capacity build in Australia gives the company a "credible base from which to deploy," contends Compass.
